PL230364A1 - - Google Patents

Info

Publication number
PL230364A1
PL230364A1 PL23036481A PL23036481A PL230364A1 PL 230364 A1 PL230364 A1 PL 230364A1 PL 23036481 A PL23036481 A PL 23036481A PL 23036481 A PL23036481 A PL 23036481A PL 230364 A1 PL230364 A1 PL 230364A1
Authority
PL
Poland
Application number
PL23036481A
Other versions
PL132428B1 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL230364A1 publication Critical patent/PL230364A1/xx
Publication of PL132428B1 publication Critical patent/PL132428B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL1981230364A 1980-03-28 1981-03-27 Proces for preparing novel derivatives of 3-/1-piperidinalkyl/-nh-pyrido-/1,2-a/-pyrimidin-4-one PL132428B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13484580A 1980-03-28 1980-03-28

Publications (2)

Publication Number Publication Date
PL230364A1 true PL230364A1 (esLanguage) 1982-03-29
PL132428B1 PL132428B1 (en) 1985-03-30

Family

ID=22465278

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1981233902A PL131162B1 (en) 1980-03-28 1981-03-27 Process for preparing novel derivatives of 4h-pyrido /1,2-a/ pyrimidin-4-one
PL1981230364A PL132428B1 (en) 1980-03-28 1981-03-27 Proces for preparing novel derivatives of 3-/1-piperidinalkyl/-nh-pyrido-/1,2-a/-pyrimidin-4-one

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL1981233902A PL131162B1 (en) 1980-03-28 1981-03-27 Process for preparing novel derivatives of 4h-pyrido /1,2-a/ pyrimidin-4-one

Country Status (5)

Country Link
JP (1) JPS56150091A (esLanguage)
KR (2) KR850000412B1 (esLanguage)
PL (2) PL131162B1 (esLanguage)
SU (1) SU1093251A3 (esLanguage)
ZA (1) ZA812085B (esLanguage)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0615529B2 (ja) * 1985-04-01 1994-03-02 エーザイ株式会社 新規ピペリジン誘導体
NZ228447A (en) * 1988-03-28 1990-08-28 Janssen Pharmaceutica Nv Cosmetic or pharmaceutical composition possessing serotonin antogonistic activity
CN101970427A (zh) * 2008-02-29 2011-02-09 Vm生物医药公司 治疗疼痛症状及其它失调的方法
EP2812004B1 (en) * 2012-02-10 2018-06-27 PTC Therapeutics, Inc. Compounds for treating spinal muscular atrophy
EP4249472A3 (en) 2015-05-30 2023-12-13 PTC Therapeutics, Inc. Methods for modulating rna splicing
ES2879995T3 (es) 2015-12-10 2021-11-23 Ptc Therapeutics Inc Métodos para el tratamiento de la enfermedad de Huntington
EA201991309A1 (ru) 2016-11-28 2019-11-29 Способы модуляции сплайсинга рнк
EP4151627A1 (en) 2017-06-05 2023-03-22 PTC Therapeutics, Inc. Compounds for treating huntington's disease
AU2018284853A1 (en) 2017-06-14 2019-12-19 Ptc Therapeutics, Inc. Methods for modifying RNA splicing
CN111163838B (zh) 2017-06-28 2023-03-28 Ptc医疗公司 用于治疗亨廷顿氏病的方法
MX2019015578A (es) 2017-06-28 2020-07-28 Ptc Therapeutics Inc Metodos para tratar la enfermedad de huntington.
MX2020009957A (es) 2018-03-27 2021-01-15 Ptc Therapeutics Inc Compuestos para el tratamiento de enfermedad de hungtinton.
SG11202012674PA (en) 2018-06-27 2021-01-28 Ptc Therapeutics Inc Heterocyclic and heteroaryl compounds for treating huntington's disease
WO2020005882A1 (en) 2018-06-27 2020-01-02 Ptc Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
EA202092899A1 (ru) 2018-06-27 2021-05-14 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Гетероарильные соединения для лечения болезни гентингтона

Also Published As

Publication number Publication date
SU1093251A3 (ru) 1984-05-15
PL233902A1 (esLanguage) 1982-07-19
KR830005220A (ko) 1983-08-03
ZA812085B (en) 1982-11-24
KR850000412B1 (ko) 1985-03-26
JPH0215550B2 (esLanguage) 1990-04-12
JPS56150091A (en) 1981-11-20
PL132428B1 (en) 1985-03-30
PL131162B1 (en) 1984-10-31
KR850000413B1 (ko) 1985-03-26

Similar Documents

Publication Publication Date Title
FR2473180B1 (esLanguage)
DE3152593A1 (esLanguage)
FR2473578B1 (esLanguage)
CH655632B (esLanguage)
FR2473575B1 (esLanguage)
BR8108722A (esLanguage)
DE3153460A1 (esLanguage)
FR2473151B1 (esLanguage)
FR2473394B1 (esLanguage)
DE3152509T1 (esLanguage)
CH627610GA3 (esLanguage)
CH655684B (esLanguage)
CH660829GA3 (esLanguage)
DE3153254A1 (esLanguage)
FR2473031B1 (esLanguage)
FR2473519B1 (esLanguage)
DE3153680A1 (esLanguage)
FR2473488B1 (esLanguage)
CH655411B (esLanguage)
CH647640GA3 (esLanguage)
DE3050629A1 (esLanguage)
CH655674B (esLanguage)
FR2473437B1 (esLanguage)
FR2472923B1 (esLanguage)
FR2473595B1 (esLanguage)